IPS-02101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIPS-02101
Drug Alias Nameintegrin alpha-V/beta-3/osteopontin antagonists (InnoPharmaScreen)IPS-02101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteopontin antagonistsIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3Osteopontin
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoPharmaScreen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoPharmaScreen Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A